ArticleMolecular oncology2022

The PI3K/mTOR inhibitor Gedatolisib eliminates dormant breast cancer cells in organotypic culture, but fails to prevent metastasis in preclinical settings.

Ryann E Shor et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.